Differential characteristics and in vitro angiogenesis of bone marrow- and peripheral blood-derived endothelial progenitor cells: Evidence from avian species

Cell Proliferation

Volumn 47, Issue 4, 2014, Pages 290-298

  Shah, Q A ^a   Tan, X ^a   Bi, S ^a   Liu, X ^a   Hu, S ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD31 ANTIGEN; LECTIN; LOW DENSITY LIPOPROTEIN; VASCULOTROPIN RECEPTOR 2;

ADIPOCYTE; ADIPOGENESIS; ANGIOGENESIS; ANIMAL CELL; ARTICLE; BIRD; BONE DEVELOPMENT; BONE MARROW; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; ENDOTHELIAL PROGENITOR CELL; GENE EXPRESSION; IN VITRO STUDY; NONHUMAN; OSTEOBLAST; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE;

ANIMALS; ANTIGENS, CD; BONE MARROW CELLS; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHICKENS; ENDOTHELIAL CELLS; GLYCOPROTEINS; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDES; STEM CELLS;

EID: 84903736011     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12111     Document Type: Article

References (40)

1. Fan CL, Gao PJ, Che ZQ, Liu JJ, Wei J, Zhu DL (2005) Therapeutic neovascularization by autologous transplantation with expanded endothelial progenitor cells from peripheral blood into ischemic hind limbs. Acta Pharmacol. Sin. 26, 1069-1075.
2. Li DW, Liu ZQ, Wei J, Liu Y, Hu LS (2012) Contribution of endothelial progenitor cells to neovascularization (Review). Int. J. Mol. Med. 30, 1000-1006.
3. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, Ishida A et al. (1998) Evidence for circulating bone marrow-derived endothelial cells. Blood 92, 362-367.
4. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964-967.
5. Dong C, Goldschmidt-Clermont PJ (2007) Endothelial progenitor cells: a promising therapeutic alternative for cardiovascular disease. J. Interv. Cardiol. 20, 93-99.
6. Yao L, Heuser-Baker J, Herlea-Pana O, Iida R, Wang Q, Zou MH et al. (2012) Bone marrow endothelial progenitors augment atherosclerotic plaque regression in a mouse model of plasma lipid lowering. Stem Cells 30, 2720-2731.
7. Briasoulis A, Tousoulis D, Antoniades C, Papageorgiou N, Stefanadis C (2011) The role of endothelial progenitor cells in vascular repair after arterial injury and atherosclerotic plaque development. Cardiovasc. Ther. 29, 125-139.
8. Young PP, Hofling AA, Sands MS (2002) VEGF increases engraftment of bone marrow-derived endothelial progenitor cells (EPCs) into vasculature of newborn murine recipients. Proc. Natl. Acad. Sci. USA 99, 11951-11956.
9. Zampetaki A, Kirton JP, Xu Q (2008) Vascular repair by endothelial progenitor cells. Cardiovasc. Res. 78, 413-421.
10. Kahler CM, Wechselberger J, Hilbe W, Gschwendtner A, Colleselli D, Niederegger H et al. (2007) Peripheral infusion of rat bone marrow derived endothelial progenitor cells leads to homing in acute lung injury. Respir. Res. 8, 50.
11. Muscari C, Gamberini C, Basile I, Bonafe F, Valgimigli S, Capitani O et al. (2010) Comparison between culture conditions improving growth and differentiation of blood and bone marrow cells committed to the endothelial cell lineage. Biol. Proced. Online 12, 9023.
12. Luo TH, Wang Y, Lu ZM, Zhou H, Xue XC, Bi JW et al. (2009) The change and effect of endothelial progenitor cells in pig with multiple organ dysfunction syndromes. Crit. Care 13, R118.
13. Amini AR, Laurencin CT, Nukavarapu SP (2012) Differential analysis of peripheral blood- and bone marrow-derived endothelial progenitor cells for enhanced vascularization in bone tissue engineering. J. Orthop. Res. 30, 1507-1515.
14. Tura O, Skinner EM, Barclay GR, Samuel K, Gallagher RC, Brittan M et al. (2013) Late outgrowth endothelial cells resemble mature endothelial cells and are not derived from bone marrow. Stem Cells 31, 338-348.
15. Moghadasian MH (2002) Experimental atherosclerosis: a historical overview. Life Sci. 70, 855-865.
16. Ayala I, Perez BG, Domenech G, Castells MT, Valdes M (2005) Use of the chicken as an experimental animal model in atherosclerosis. Avian Poult. Biol. Rev. 16, 151-159.
17. Tan X, Chai J, Bi SC, Li JJ, Li WW, Zhou JY (2012) Involvement of matrix metalloproteinase-2 in medial hypertrophy of pulmonary arterioles in broiler chickens with pulmonary arterial hypertension. Vet. J. 193, 420-425.
18. Wideman RJ, Hamal KR (2011) Idiopathic pulmonary arterial hypertension: an avian model for plexogenic arteriopathy and serotonergic vasoconstriction. J. Pharmacol. Toxicol. Methods 63, 283-295.
19. Casamassimi A, Balestrieri ML, Fiorito C, Schiano C, Maione C, Rossiello R et al. (2007) Comparison between total endothelial progenitor cell isolation versus enriched CD133 + culture. J. Biochem. 141, 503-511.
20. Jazayeri M, Allameh A, Soleimani M, Jazayeri SH, Piryaei A, Kazemnejad S (2008) Molecular and ultrastructural characterization of endothelial cells differentiated from human bone marrow mesenchymal stem cells. Cell Biol. Int. 32, 1183-1192.
21. Chen JY, Feng L, Zhang HL, Li JC, Yang XW, Cao XL et al. (2012) Differential regulation of bone marrow-derived endothelial progenitor cells and endothelial outgrowth cells by the Notch signaling pathway. PLoS One 7, e43643.
22. Hur J, Yoon CH, Kim HS, Choi JH, Kang HJ, Hwang KK et al. (2004) Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler. Thromb. Vasc. Biol. 24, 288-293.
23. Yang N, Li D, Jiao P, Chen B, Yao S, Sang H et al. (2011) The characteristics of endothelial progenitor cells derived from mononuclear cells of rat bone marrow in different culture conditions. Cytotechnology 63, 217-226.
24. de la Puente P, Muz B, Azab F, Azab AK (2013) Cell trafficking of endothelial progenitor cells in tumor progression. Clin. Cancer Res. 19, 3360-3368.
25. Friedrich EB, Walenta K, Scharlau J, Nickenig G, Werner N (2006) CD34-/CD133 + /VEGFR-2 + endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ. Res. 98, e20-e25.
26. Hristov M, Erl W, Linder S, Weber PC (2004) Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. Blood 104, 2761-2766.
27. Shibata R, Skurk C, Ouchi N, Galasso G, Kondo K, Ohashi T et al. (2008) Adiponectin promotes endothelial progenitor cell number and function. FEBS Lett. 582, 1607-1612.
28. Cao C, Zhang H, Gong L, He Y, Zhang N (2012) High glucose conditions suppress the function of bone marrow-derived endothelial progenitor cells via inhibition of the eNOS-caveolin-1 complex. Mol. Med. Rep. 5, 341-346.
29. Rafii S, Lyden D (2003) Therapeutic stem and progenitor cell transplantation for organ vascularization and regeneration. Nat. Med. 9, 702-712.
30. Fedorovich NE, Haverslag RT, Dhert WJ, Alblas J (2010) The role of endothelial progenitor cells in prevascularized bone tissue engineering: development of heterogeneous constructs. Tissue Eng. Part A 16, 2355-2367.
31. Malinowski M, Pietraszek K, Perreau C, Boguslawski M, Decot V, Stoltz JF et al. (2012) Effect of lumican on the migration of human mesenchymal stem cells and endothelial progenitor cells: involvement of matrix metalloproteinase-14. PLoS One 7, e50709.
32. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR et al. (2002) Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 418, 41-49.
33. Yoo HJ, Yoon SS, Park S, Park WS, Kim DJ, Lee EB et al. (2005) Production and characterization of monoclonal antibodies to mesenchymal stem cells derived from human bone marrow. Hybridoma (Larchmt) 24, 92-97.
34. Chong PP, Selvaratnam L, Abbas AA, Kamarul T (2012) Human peripheral blood derived mesenchymal stem cells demonstrate similar characteristics and chondrogenic differentiation potential to bone marrow derived mesenchymal stem cells. J. Orthop. Res. 30, 634-642.
35. Pozzobon M, Piccoli M, Ditadi A, Bollini S, Destro R, Andre-Schmutz I et al. (2009) Mesenchymal stromal cells can be derived from bone marrow CD133+ cells: implications for therapy. Stem Cells Dev. 18, 497-510.
36. Tondreau T, Meuleman N, Delforge A, Dejeneffe M, Leroy R, Massy M et al. (2005) Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells 23, 1105-1112.
37. Kwon SM, Lee YK, Yokoyama A, Jung SY, Masuda H, Kawamoto A et al. (2011) Differential activity of bone marrow hematopoietic stem cell subpopulations for EPC development and ischemic neovascularization. J. Mol. Cell. Cardiol. 51, 308-317.
38. Jianguo W, Tianhang L, Hong Z, Zhengmao L, Jianwei B, Xuchao X et al. (2010) Optimization of culture conditions for endothelial progenitor cells from porcine bone marrow in vitro. Cell Prolif. 43, 418-426.
39. Li M, Li S, Yu L, Wu J, She T, Gan Y et al. (2013) Bone mesenchymal stem cells contributed to the neointimal formation after arterial injury. PLoS One 8, e82743.
40. Schlosser S, Dennler C, Schweizer R, Eberli D, Stein JV, Enzmann V et al. (2012) Paracrine effects of mesenchymal stem cells enhance vascular regeneration in ischemic murine skin. Microvasc. Res. 83, 267-275.